WebNov 19, 2024 · Per the agreement, Novo Nordisk will begin a cash tender offer to acquire all outstanding shares of Dicerna’s common stock for $38.25 per share in cash. The … WebMay 24, 2024 · Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) is a biopharmaceutical company focused on discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid ...
Novo Nordisk to Acquire Dicerna Business Wire
WebDicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for rare, chronic liver, cardiovascular, and viral infectious diseases in the United States and internationally. ... Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire ... WebNov 18, 2024 · Once the tender offer is complete, Dicerna Pharmaceuticals will merge with the Novo Nordisk subsidiary. Any shares not part of the offer will be canceled and … north one pty ltd
Dicerna Pharmaceuticals Inc - AnnualReports.com
WebNovo Nordisk announces completion of Dicerna Pharmaceuticals acquisition. Bagsværd, Denmark, 28 December 2024 – Novo Nordisk today announced that the acquisition of … WebDicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary … WebDec 26, 2024 · Unless the tender offer is extended, the offer and withdrawal rights will expire on December 27, 2024. On November 18, 2024, Dicerna agreed to be acquired by Novo Nordisk A/S (NVO) for $38.25 per ... north one jackson mi